CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients

Jin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, In Sil Choi, Sang-Il Kim, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim

Cancer Research and Treatment. 2004;36(6):372-376. Published online 2004 December 31 DOI: https://doi.org/10.4143/crt.2004.36.6.372

Open-label, Randomized Comparison of the Efficacy of Intravenous Dolasetron Mesylate and Ondansetron in the Prevention of Acute and Delayed Cisplatin-induced Emesis in Cancer Patients

Jin-Soo Kim, Ji Yeon Baek, Sook Ryun Park, In Sil Choi, Sang-Il Kim, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang, Noe Kyeong Kim

Cancer Research and Treatment. 2004;36(6):372

Link1

Link2

1224 An open label study of tropisetron for acute and delayed cisplatin-induced emesis

I.N. Olver

European Journal of Cancer. 1995;31:S256

Link1 Link2

Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles

B Chevallier, , M Marty, J-M Paillarse

British Journal of Cancer. 1994;70(6):1171-1175

Link1 Link2

Link3

A Randomized, Multicenter, Open-Label Comparison of the Antiemetic Efficacy of Dolasetron Versus Ondansetron for the Prevention of Nausea and Vomiting During High-Dose Myeloablative Chemotherapy

Romeo A. Mandanas, Roy Beveridge, Robert M. Rifkin, Hugh Wallace, Andrew Greenspan, Lina Asmar

Supportive Cancer Therapy. 2005;2(2):114-121

Link1 Link2

Randomized double-blind comparison of three dose levels of intravenous ondansetron in the prevention of cisplatin-induced emesis

Steven M. Grunberg, Montague Lane, Eric P. Lester, Kasi S. Sridhar, Joanne Mortimer, William Murphy, Polly E. Sanderson

Cancer Chemotherapy and Pharmacology. 1993;32(4):268-272

Link1

Link2 Link3

Efficacy of granisetron for the prevention of cisplatin-induced emesis in lung cancer patients

Lung Cancer. 1994;11:88

Link1 Link2

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret

J.A. Rudd, R.J. Naylor

British Journal of Pharmacology. 1996;118(2):209-214

Link1 Link2

Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis

H. Tsukada, T. Hirose, A. Yokoyama, Y. Kurita

European Journal of Cancer. 2001;37(18):2398-2404

Link1 Link2

An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens

A. Martoni, B. Angelelli, M. Guaraldi, E. Strocchi, F. Pannuti

European Journal of Cancer. 1996;32(1):82-85

Link1 Link2

Comparative efficacy of a single oral dose of ondansetron and of buspirone against cisplatin-induced emesis in cancer patients

AB Alfieri, LX Cubeddu

British Journal of Cancer. 1995;72(4):1013-1015

Link1

Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.